PDR® Physicians Desk Reference® 2004 Book

Beschreibung

The Authoritative Source of FDA-Approved Information on Prescription Drugs. Physicians have turned to PDR® for the latest word on prescription drugs for 58 years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital and pharmacy in the United States. In fact, nine out of ten doctors consider PDR their most important reference source. The 58th edition is more than 3,000 pagesour most comprehensive edition ever! These critical new drugs are included in the 2004 edition: Zetia (ezetimibe), the first of a new class of lipid-lowering compounds that selectively inhibits intestinal absorption of cholesterol and related phytosterols. Strattera (atomoxetine HCl), the first selective norepinephrine reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder (ADHD). Pediarix (diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B [recombinant] and inactivated poliovirus vaccine combined), the first five-in-one vaccine/toxoid combination indicated as a 3-dose primary series to infants at 2, 4, and 6 months old for active immunization against diphtheria, tetanus, pertussis, hepatitis B, and polio. Forteo (teriparatide[rDNA origin]), a new recombinant human parathyroid hormone for the treatment of postmenopausal women with osteoporosis, and to increase bone mass in men with primary or hypogonadal osteoporosis. Humira (adalimumab), a new recombinant human monoclonal antibody for reducing signs and symptoms and inhibiting the progression of structural damage in adults with moderately to severely active rheumatoid arthritis. Cipro XR (ciprofloxacin extended-release), a new extended-release fluoroquinolone for the treatment of uncomplicated urinary tract infections (acute cystitis) caused by Escherichia coli, Proteus mirabilis, Enterococcus faecalis, or Staphylococcus saprophyticus. Amevive (alefacept), an immunosuppressive agent for the treatment of patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy. You'll find the most complete data on over 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer, and product category. Your 2004 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the product information. You will also find: Phonetic spelling for most listings A key to controlled substances FDA use-in-pregnancy ratings Contraindications Dosages Clinical pharmacology Adverse reactions Pediatric use All other FDA-required information On average, over 70% of the drugs found in PDR have prescribing information that has been updated from that found in the previous years' edition. This means that each year thousands of changes are made to drugs. Among these changes are: Interactions with other drugs Side Effects Recommended Dosages Contraindications Black box warnings How supplied methods For absolutely accurate information, you need the 2004 PDR!

Autor*in

Stimmen zu »PDR® Physicians Desk Reference® 2004 Book«

Details

Link teilen